Infant Feeding And Glp1 - Gallery & Information

Infant Feeding and GLP-1: What You Need to Know

The Basics of GLP-1

Glucagon-like peptide-1 (GLP-1) is a hormone that plays a crucial role in regulating appetite, blood sugar levels, and metabolism. GLP-1 receptor agonists, such as semaglutide and liraglutide, are medications that mimic the action of GLP-1 and are used to treat type 2 diabetes and obesity. These medications work by slowing down stomach emptying, reducing appetite, and improving insulin sensitivity.

GLP-1 and Breastfeeding: The Safety Concerns

While GLP-1 medications have become increasingly popular for weight loss and diabetes management, there are concerns about their safety during breastfeeding. The main concern is that GLP-1 medications may pass into breast milk and affect the baby. However, the extent to which GLP-1 medications are excreted into breast milk is not well understood, and more research is needed to determine the potential risks.

The Current State of Research

Several studies have investigated the safety of GLP-1 medications during breastfeeding, but the results are inconsistent and often based on small sample sizes. A 2023 study published in the Journal of Clinical Endocrinology and Metabolism found that semaglutide, a popular GLP-1 medication, was not detectable in breast milk after 4 months of breastfeeding. However, another study published in 2024 found that GLP-1 concentrations were higher in breast milk than in blood, suggesting that GLP-1 may be transferred to the baby through breast milk.

The Risks of GLP-1 to Infants

While the exact risks of GLP-1 to infants are not well understood, there are concerns that GLP-1 may affect the baby's growth and development. A 2024 study published in the journal Diabetes, Obesity and Metabolism found that GLP-1 agonists may affect fetal weight, growth, and skeletal ossification in animal studies. However, more research is needed to determine whether GLP-1 has similar effects in humans.

Alternatives to GLP-1 During Breastfeeding

If you are breastfeeding and considering weight loss or diabetes management, there are alternative options to GLP-1 medications. Metformin, a medication commonly used to treat type 2 diabetes, is generally considered safe during breastfeeding. Insulin, which is the gold standard for diabetes management, is also safe during breastfeeding and has extensive safety data.

Conclusion

While GLP-1 medications have become increasingly popular for weight loss and diabetes management, the safety of these medications during breastfeeding is a concern. More research is needed to determine the potential risks of GLP-1 to infants, and alternative options should be considered for breastfeeding mothers. If you are breastfeeding and considering GLP-1, it is essential to discuss your options with your healthcare provider to determine the best course of action for your individual situation.

Recommendations

* Consult with your healthcare provider before taking GLP-1 medications while breastfeeding. * Consider alternative options, such as metformin or insulin, for weight loss and diabetes management. * Monitor your baby's growth and development closely if you are taking GLP-1 medications while breastfeeding. * Stay informed about the latest research on GLP-1 and breastfeeding to make informed decisions about your health.

References

* Muller DRP, Stenvers DJ, Malekzadeh A, et al. Effects of GLP-1 agonists and SGLT2 inhibitors during pregnancy and lactation on offspring outcomes: a systematic review of the evidence. * Santoro N, et al. Effects of GLP-1 receptor agonists on fetal growth and development in animal models. * Tian H, et al. GLP-1 agonists and SGLT2 inhibitors during pregnancy and lactation: a systematic review.

Additional Resources

* National Institute of Child Health and Human Development. (2022). GLP-1 and Breastfeeding. * American Diabetes Association. (2022). GLP-1 and Pregnancy. * Mayo Clinic. (2022). GLP-1 and Breastfeeding.

📁 Category: Glp-1

🏷️ Tags: #infant feeding and glp-1 #infant #feeding #glp-1 #battery voltage warning system #search trademark by date of trademark registration #infrared red light facial

Gallery Photos

Subcutaneous Semaglutide during Breastfeeding: Infant Safety Regarding ...

Aug 28, 2024The introduction ofGLP-1agonists to augment weight loss has become a topic of interest for many postpartum mothers. Our study aims to investigate the transmission of semaglutide into human milk in the first steps to ensure the safety and health of both lactating mothers and their breastfedinfants.

source: https://pubmed.ncbi.nlm.nih.gov

Can You Use GLP‐1 Medications While Breastfeeding? Here's What We Know

Jun 24, 2025Let's dig into what we actually know aboutGLP‑1medications and breastfeeding. I've broken down the latest research, especially from the InfantRisk Center, and created a balanced look at the pros and cons.

source: https://www.thebreastfeedingmama.com

Is Semaglutide Safe While Breastfeeding? - TODAY

Oct 21, 2025There's growing interest among women to takeGLP-1drugs like semaglutide for weight loss after giving birth and while breastfeeding. Is it safe for the baby? Doctors explain.

source: https://www.today.com

GLP 1 levels in breastmilk after Semaglutide - InfantRisk Forums

Jan 23, 2025Today's Posts Mark Channels Read Forum Medications and Breastfeeding Mothers Diabetic Medications The recommendations the InfantRisk Center provides are not meant to replace medical advice from your physician. The ultimate decision to breastfeed while taking medications should be based on an informed decision including available data, discussions between a mother, her physician, and the ...

source: https://www.infantrisk.com

Can you take GLP-1 while breastfeeding? What the research actually ...

Feb 12, 2026Can you takeGLP-1while breastfeeding? Review the latest semaglutide and tirzepatide lactation studies, safety data, and postpartum alternatives.

source: https://www.seekpeptides.com

Is GLP-1 Safe for Breastfeeding Moms? Safety Guide

IsGLP-1safe for breastfeeding moms? Learn about the limited safety data, FDA guidance, potential risks to nursinginfants,andsafer alternatives for diabetes and weight management during lactation.

source: https://www.baddie.health

GLP-1 Medications and Breastfeeding: What Moms Need to Know

GLP-1receptor agonists (like semaglutide, liraglutide, or tirzepatide) were originally developed to help manage type 2 diabetes by improving blood sugar control. They also slow stomach emptying and reduce appetite — which is why they've become widely used for weight loss. They can be effective, but they're also powerful medications — and their safety depends on timing, body needs, and ...

source: https://natashamommd.substack.com

Safety of Using Semaglutide During Lactation - IABLE

Sep 17, 2024The introduction ofGLP-1agonists to augment weight loss has become a topic of interest for many postpartum mothers. Our study aims to investigate the transmission of semaglutide into human milk in the first steps to ensure the safety and health of both lactating mothers and their breastfedinfants.

source: https://lacted.org

Are Glucagon-like peptide (GLP) injectables contraindicated in ...

May 6, 2025GLP-1receptor agonist injectables are not recommended for someone who is breastfeeding due to limited safety data and potential risks to the nursinginfant. The most recent and highest quality study, published in 20231, lists pregnancy and breastfeeding as contraindications for semaglutide, aGLP-1analog.

source: https://www.droracle.ai

Is GLP-1 therapy recommended during breastfeeding?

GLP-1medications are not recommended during breastfeeding. At Alloy, your safety and your baby's safety are our top priorities. While there is limited data in breastfeeding women, current guidance is to avoidGLP-1therapy if you are pregnant or breastfeeding. In this discussion with Dr. Rocio Salas-Whalen, she explains that although theGLP-1molecule is large and would likely be broken ...

source: https://www.myalloy.com

Laurel Wilson » Feeding Families in the Age of GLP-1s: Protecting Milk ...

WIC staff are increasingly encountering families with questions about milk supply, appetite suppression, nutrition adequacy, andinfantfeedingbehaviors - often without clear guidance. Participants will gain a practical, evidence-informed understanding of howGLP-1medications may impact lactation, maternal/parental nutrition, andinfant...

source: https://lactspeak.com

Common GLP-1 Questions, Answered by Weight Loss Experts at U of U ...

2 days agoGLP-1sare everywhere—but what's fact and what's fiction? University of Utah Health weight loss experts answer the most common questions with clear, trusted medical insight.

source: https://healthcare.utah.edu

An Age-by-Age Feeding Chart for Newborns and Babies - Parents

Jul 21, 2025All babies have different nutritional needs, but this babyfeedingchart suggests when and how much to feed them during their first year. Here's what to know.

source: https://www.parents.com

Boston Mayor Wu, unions strike deal to limit GLP-1 weight loss drug ...

TodayBoston Mayor Michelle Wu said her administration has reached a deal with City Hall unions to limitGLP-1drug coverage for weight loss that will save the city roughly $10.6 million and curb ...

source: https://www.bostonherald.com

Circulating GLP-1 in infants born small-for-gestational-age: breast ...

Prenatal growth restraint associates with the risk for later diabetes, particularly if such restraint is followed by postnatal formula-feeding(FOF) rather than breast-feeding(BRF). Circulating incretins can influence the neonatal programming of hypothalamic setpoints for appetite and energy expend …